Repository logo
 
Publication

FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence

2022-01-06Journal article Restricted access
Simple item page
dc.contributor.authorSimões, Catarina D.
dc.contributor.authorMaganinho, Marta
dc.contributor.authorSousa, Ana S.
dc.date.accessioned2022-01-13T12:50:07Z
dc.date.available2022-01-13T12:50:07Z
dc.date.issued2022-01-06
dc.description.abstractPurpose Based on the fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) hypothesis, the low-FODMAP diet has been suggested as a potential therapeutic approach for inflammatory bowel disease (IBD) with promising results on disease management. However, this diet implies a specific broad food restriction, which potentially increases the risk of nutritional deficiencies and may aggravate gut microbiota dysbiosis of IBD patients. The aim of the present study is to review the effect of individual FODMAPs on the human gut microbiota. In addition, this narrative review provides an updated overview of the use of the low-FODMAP diet in IBD, namely the implementation, advantages, limitations, and the impact on the gut microbiota. Methods The literature search strategy was applied to PubMed and Web of Science using relevant keywords, IBD, FODMAPs, Fructose, Lactose, Polyols, FOS, GOS, low-FODMAP diet and gut microbiota. Results Current data suggest that the low-FODMAP diet may effectively improve clinical outcomes in the management of IBD and ensure better quality of life for IBD patients. However, there is evidence highlighting some issues of concern, particularly the adequacy of the diet and the impact on the gut microbiota. The various FODMAP types differently modulate the gut microbiota. Conclusion IBD management should be achieved with the least possible dietary restriction to avoid detrimental consequences, particularly on nutritional adequacy and gut microbiota. Thus, it is important to individualize and monitor the nutrition intervention. Further studies are required to better characterize the relationship between diet, the gut microbiota, and IBD to support the generalization of this approach for clinical practice in IBD therapy and management.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationSimões, C.D., Maganinho, M. & Sousa, A.S. FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence. Eur J Nutr (2022). https://doi.org/10.1007/s00394-021-02755-1pt_PT
dc.identifier.doihttps://doi.org/10.1007/s00394-021-02755-1pt_PT
dc.identifier.issn1436-6207
dc.identifier.urihttp://hdl.handle.net/10284/10632
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s00394-021-02755-1pt_PT
dc.subjectFODMAPspt_PT
dc.subjectMicrobiotapt_PT
dc.subjectInflammatory bowel diseasespt_PT
dc.subjectLow-FODMAP dietpt_PT
dc.subjectDiet therapypt_PT
dc.titleFODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidencept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleEuropean Journal of Nutritionpt_PT
person.familyNameSimões
person.familyNameSousa
person.givenNameCatarina
person.givenNameAna Sofia
person.identifier.ciencia-idC418-AE5B-96D3
person.identifier.orcid0000-0002-4213-8951
person.identifier.orcid0000-0001-6093-0208
person.identifier.scopus-author-id56425114300
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicatione95d97ad-180a-42bb-b50f-0511aa5a637d
relation.isAuthorOfPublication3b06d6d2-fe03-42b8-ab51-6e2b66609aaf
relation.isAuthorOfPublication.latestForDiscoverye95d97ad-180a-42bb-b50f-0511aa5a637d

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Simoes_etal-2022-EurJNutr.pdf
Size:
808.96 KB
Format:
Adobe Portable Document Format
Download

Collections

FCS - Artigos em Revistas Científicas Internacionais com Arbitragem Científica